EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Development and Evaluation of Microencapsulated Oregano Essential Oil as an Alternative Treatment for Candida albicans Infections

Liliana Fernandes, Ainara Barco-Tejada, Elena Blázquez, Daniela Araújo, Artur Ribeiro iD, Sónia Silva iD, Lorena Cussó, Sofia Costa-de-Oliveira iD, M Elisa Rodrigues iD, Mariana Henriques

ACS Applied Materials & Interfaces · 2024

DOI: 10.1021/acsami.4c07413 ↗

At a glance

Journal article in ACS Applied Materials & Interfaces, 2024. Written by Liliana Fernandes and 9 co-authors. Institution: Centre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal. Major MEDLINE topics: Candida albicans, Oils, Volatile, Candidiasis, Vulvovaginal, Mice, Inbred BALB C. Cited 10 times so far (Crossref); 68 references. The full text is freely available (open access, CC BY 4.0). Funded by: Comunidad de Madrid, European Commission, European Regional Development Fund.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Vulvovaginal candidiasis (VVC) is characterized as a very common fungal infection that significantly affects women's health worldwide. Essential oils (EOs) are currently being evaluated as an alternative therapy. The development of efficient techniques such as micro- or nanoencapsulation for protecting and controlling release is essential to overcome the limitations of EO applications. Therefore, the aim of this study was to develop and characterize oregano EO-loaded keratin microparticles (OEO-KMPs) as a potential treatment for VVC. OEO-KMPs were produced using high-intensity ultrasonic cycles and characterized in terms of morphological and physicochemical parameters. In vitro evaluation included assessing the toxicity of the OEO-KMPs and their effect against Candida albicans using microdilution and agar diffusion, while the activity against biofilm was quantified using colony forming units (CFU). The efficacy of the OEO-KMPs in an in vivo VVC mouse model was also studied. Female BALB/c mice were intravaginally infected with C. albicans, 24 h postinfection animals were treated intravaginally with 15 μL of OEO-KMPs and 24 h later vaginal fluid was analyzed for C. albicans and Lactobacillus growth (CFU mL-1). The results showed the stability of the OEO-KMPs over time, with high encapsulation efficiency and controlled release. This nanoparticle size facilitated penetration and completely inhibited the planktonic growth of C. albicans. In addition, an in vitro application of 2.5% of the OEO-KMPs eradicated mature C. albicans biofilms while preserving Lactobacillus species. In in vivo, a single intravaginal application of OEO-KMPs induced a reduction in C. albicans growth, while maintaining Lactobacillus species. In conclusion, this therapeutic approach with OEO-KMPs is promising as a potential alternative or complementary therapy for VVC while preserving vaginal microflora.

Subjects

MeSH terms (MEDLINE)

Candida albicansOils, VolatileCandidiasis, VulvovaginalMice, Inbred BALB CAntifungal AgentsOriganumAnimalsFemaleMiceBiofilmsMicrobial Sensitivity TestsHumans

Author keywords

Biofilm treatmentCandida albicansKeratin microcapsulesPhytotherapeutic applicationsVaginal microfloraVulvovaginal candidiasis

Substances

Oils, VolatileAntifungal Agents

Authors and institutions

  • Centre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
  • Departamento de Bioingeniería, Universidad Carlos III de Madrid, 126, 28903 Getafe, Madrid, Spain.
  • Unidad de Medicina y Cirugía Experimenta, Instituto de Investigación Sanitaria Gregorio Marañón, 28029 Madrid, Spain.
  • National Institute for Agrarian and Veterinary Research, Vairão, 4485-655 Vila do Conde, Portugal.
  • LABBELS - Associate Laboratory, 4710-057 Braga, Portugal.
  • Advanced Imaging Unit, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), 28029 Madrid, Spain.

ORCID profiles: Artur Ribeiro, Sónia Silva, Sofia Costa-de-Oliveira, M Elisa Rodrigues

Funding

  • Comunidad de Madrid
  • European Commission
  • European Regional Development Fund
  • Instituto de Salud Carlos III
  • Funda??o para a Ci?ncia e a Tecnologia

Cite

APA

Fernandes, L., Barco-Tejada, A., Blázquez, E., Araújo, D., Ribeiro, A., Silva, S., Cussó, L., Costa-de-Oliveira, S., Rodrigues, M. E., & Henriques, M. (2024). Development and Evaluation of Microencapsulated Oregano Essential Oil as an Alternative Treatment for Candida albicans Infections. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c07413

Vancouver

Fernandes L, Barco-Tejada A, Blázquez E, Araújo D, Ribeiro A, Silva S, et al. Development and Evaluation of Microencapsulated Oregano Essential Oil as an Alternative Treatment for Candida albicans Infections. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c07413

BibTeX
@article{Fernandes2024,
  author = {Fernandes, Liliana and Barco-Tejada, Ainara and Blázquez, Elena and Araújo, Daniela and Ribeiro, Artur and Silva, Sónia and Cussó, Lorena and Costa-de-Oliveira, Sofia and Rodrigues, M Elisa and Henriques, Mariana},
  title = {Development and Evaluation of Microencapsulated Oregano Essential Oil as an Alternative Treatment for Candida albicans Infections},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  doi = {10.1021/acsami.4c07413}
}
Start for free →